INTERNATIONAL CHEMICAL INVESTORS S.E.
LATEST NEWS
ICIG announces the appointment of Dr. Michael Quirmbach as CEO & President of CordenPharma Group
26. July 2019
CordenPharma Group, the global pharmaceutical service & manufacturing platform of International Chemical Investors Group (ICIG), is pleased to announce the appointment of Dr. Michael Quirmbach as Chief Executive Officer & President, effective August 1, 2019.
Michael Quirmbach joined CordenPharma Group in October 2014 as Chief Business Officer and has been member of the Executive Leadership Team. Since then he has been instrumental in establishing CordenPharma in the market as a reputable, trustworthy and world class CDMO to the pharmaceutical industry.
Prior to joining CordenPharma, Michael Quirmbach held several management positions in the CDMO and Biotech industry with companies such as Siegfried, Dr. Reddy’s and Solvias. He holds a degree in Chemistry and a PhD from the Max Planck Research Group at the Institute for Organic Catalysis Research in Rostock (DE) as well as a MBA from La Salle University in Philadelphia (USA).
Michael Quirmbach will succeed Dr. Riku Rautsola as CEO & President of CordenPharma Group. Riku Rautsola will transition to the role of a Senior Advisor to the Executive Leadership Team, in support of a smooth transition.
The Executive Leadership Team of CordenPharma Group will consist of Dr. Michael Quirmbach as CEO & President, Dr. Walter Kittl as COO together with Heiko Serwe, CFO, and Dr. Esua Macniell, Chief Compliance Officer.
“We thank Riku Rautsola for taking the responsibility at CordenPharma at a critical time and are pleased with the appointment of Michael Quirmbach as our new CEO & President of CordenPharma Group. Michael Quirmbach has demonstrated strong leadership and was instrumental in CordenPharma’s continued growth trajectory over the last years to become a major CDMO player to the pharmaceutical industry. Our leadership team is now well positioned to accelerate plans for long-term growth. We are also pleased that Riku will continue to support ICIG and CordenPharma Group as a Senior Advisor to the Executive Leadership Team” state Dr. Achim Riemann and Patrick Schnitzer, Managing Directors of ICIG.
About CordenPharma
CordenPharma, the global pharmaceutical service & manufacturing platform of International Chemical Investors Group (ICIG), is a full-service partner in the Contract Development & Manufacturing (CDMO) of APIs, Drug Products, and associated Packaging Services. Through a growing network of cGMP facilities across Europe and the US organized under four Technology Platforms – Peptides, Lipids & Carbohydrates; Injectables; Highly Potent & Oncology; and Small Molecules – CordenPharma experts translate complex processes, ideas and projects at any stage of development into high-value products. For more information visit www.cordenpharma.com.
About International Chemical Investors Group
International Chemical Investors is a privately owned industrial group with sales in excess of EUR 2 billion and more than 5,200 employees worldwide. ICIG is focusing on three main platforms: Pharmaceuticals under the CordenPharma brand, Fine Chemicals under the WeylChem brand and Chlorovinyls under the Vynova brand. Since inception in 2004, ICIG has grown to operate 25 independent chemicals and pharmaceutical businesses in Europe and the United States, all of which have origins in major global chemical or pharmaceutical corporations. For more information about ICIG: www.ic-investors.com.
Contact:
International Chemical Investors Group
Sibel Cumcu
Phone: +49 69 506 999 0
Email: Info@ic-investors.com
ALLE WEITEREN NACHRICHTEN
Thann production site joins Vynova Group, reinforcing Vynova’s leading position in potassium derivatives
On 1 July 2019, Potasse et Produits Chimiques SAS has joined Vynova Group. The company, based in Thann (France), has been renamed Vynova PPC SAS. The site’s integration is the final step in a journey of continually increasing cooperation and will...
WeylChem Group acquires the homecare and process catalyst business of Catexel Group
Effective November 1, 2018, International Chemical Investors Group (ICIG) and WeylChem Group have acquired the Homecare, Cellulosics and Synthesis business of Catexel Group from Unilever Ventures. By acquiring Catexel Technologies Ltd. and Catexel...
Vynova inaugurates new KOH membrane electrolysis facility in Tessenderlo, Belgium
Vynova Group today inaugurated its new, state-of-the-art potassium hydroxide (KOH) membrane electrolysis facility in Tessenderlo, Belgium. The plant is the result of a major conversion project which was concluded in April 2018, ahead of schedule. The...
ICIG appoints new president of WeylChem: Uwe Brunk to succeed Frank Wegener
Effective October 1, 2018, Dr. Uwe Brunk (56) will join International Chemical Investors Group (ICIG) as President of the WeylChem Group of Companies. Uwe Brunk holds a PhD in Organic Chemistry from the Technical University in Berlin and an executive...
Vynova expands its Tessenderlo potassium derivatives portfolio
Wednesday, 10 January 2018 - Vynova Group has expanded the product portfolio of its Tessenderlo (Belgium) site with potassium carbonate (K2CO3) liquid. The same product is already produced on the site of Potasse et Produits Chimiques SAS (PPC) in...
Vynova continues investing: KOH conversion on track, NaOH expansion announced
Wednesday, 22 November 2017 - VYNOVA Group confirms that the construction of its new state-of-the-art potassium hydroxide (KOH) membrane electrolysis facility in Tessenderlo (Belgium) remains fully on schedule. The project is on track for completion...
CordenPharma Acquires Pfizer API Manufacturing Facility in Boulder Colorado
CordenPharma, a leading Contract Development & Manufacturing Organization (CDMO), has entered into definite agreements to acquire the former Hospira Boulder (Colorado) high containment API site from Pfizer, Inc. The closing of the transaction is...
Launch of WeylChem InnoTec – The Technology and Innovation backbone of WeylChem Group of Companies
Starting August 1st a new Chemical Service Company within the WeylChem Group of Companies has been formed. With its competencies in Analytics, Contract Research and Piloting as well as Specialized Custom Synthesis and Process development WeylChem...
Vynova joins the “Operation Clean Sweep®” program
VYNOVA has signed the Operation Clean Sweep® pledge and is committed to the clear goal of zero emissions of plastic pellets, flakes and powder to the environment. Operation Clean Sweep® (OCS) is a key sustainability program of the global plastics...
ICIG BUSINESS SERVICES
ACCOUNTING
HUMAN RESOURCES & LEGAL
INFORMATION MANAGEMENT
REPORTING
FURTHER INFOS
OUR SITES
› Homepage
› Services
› Company
› News
› Contact
SERVICES
Company
CONTACT / LOCATIONS
WUPPERTAL
ICIG Business Services
GmbH & Co. KG
Schloessersgasse 1
D- 42103 Wuppertal
FRANKFURT
ICIG Business Services
GmbH & Co. KG
c/o Allessa GmbH
Alt-Fechenheim 34
D- 60386 Frankfurt
LATEST NEWS
ICIG BUSINESS SERVICES
Summer Party & Courtyard!
Our summer party was a complete success! There was consistently positive feedback. Everyone felt comfortable, met each other and enjoyed the afternoon with good food. Even the little ones felt comfortable in the “childrens room”, when they got their...
New Premises!
The move to our new building is finally completed. On the three newly renovated floors, the new office space and the new courtyard provide a good working atmosphere. On each floor, with the help of the new kitchenettes and coffeemakers, you will enjoy...
IC INVESTORS
ICIG announces the appointment of Dr. Michael Quirmbach as CEO & President of CordenPharma Group
CordenPharma Group, the global pharmaceutical service & manufacturing platform of International Chemical Investors Group (ICIG), is pleased to announce the appointment of Dr. Michael Quirmbach as Chief Executive Officer & President, effective August...
Thann production site joins Vynova Group, reinforcing Vynova’s leading position in potassium derivatives
On 1 July 2019, Potasse et Produits Chimiques SAS has joined Vynova Group. The company, based in Thann (France), has been renamed Vynova PPC SAS. The site’s integration is the final step in a journey of continually increasing cooperation and will...
WeylChem Group acquires the homecare and process catalyst business of Catexel Group
Effective November 1, 2018, International Chemical Investors Group (ICIG) and WeylChem Group have acquired the Homecare, Cellulosics and Synthesis business of Catexel Group from Unilever Ventures. By acquiring Catexel Technologies Ltd. and Catexel...